Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety, and cost of new anticancer drugs.
Garattini S, Bertele V. Garattini S, et al. BMJ. 2002 Aug 3;325(7358):269-71. doi: 10.1136/bmj.325.7358.269. BMJ. 2002. PMID: 12153927 Free PMC article. No abstract available.
Risk:benefit assessment of old medicines.
Garattini S, Bertelé V. Garattini S, et al. Br J Clin Pharmacol. 2004 Dec;58(6):581-6. doi: 10.1111/j.1365-2125.2004.02197.x. Br J Clin Pharmacol. 2004. PMID: 15563356 Free PMC article. Review.
Orphan drug development is progressing too slowly.
Joppi R, Bertele V, Garattini S. Joppi R, et al. Br J Clin Pharmacol. 2006 Mar;61(3):355-60. doi: 10.1111/j.1365-2125.2006.02579.x. Br J Clin Pharmacol. 2006. PMID: 16487232 Free PMC article.
Do we learn the right things from clinical trials?
Garattini S, Bertele' V. Garattini S, et al. Eur J Clin Pharmacol. 2008 Feb;64(2):115-25. doi: 10.1007/s00228-007-0411-4. Epub 2008 Jan 29. Eur J Clin Pharmacol. 2008. PMID: 18228013 Review. No abstract available.
Limits of add-on trials: antirheumatic drugs.
Ottolenghi L, Bertele' V, Garattini S. Ottolenghi L, et al. Eur J Clin Pharmacol. 2009 Jan;65(1):33-41. doi: 10.1007/s00228-008-0545-z. Epub 2008 Sep 3. Eur J Clin Pharmacol. 2009. PMID: 18762934 Review.
122 results